HologicHOLXEarnings & Financial Report
Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.
Revenue
$1.0B
Gross Profit
$542.3M
Operating Profit
$210.4M
Net Profit
$169.9M
Gross Margin
53.3%
Operating Margin
20.7%
Net Margin
16.7%
YoY Growth
-0.8%
EPS
$0.72
Hologic Q2 FY2024 Financial Summary
Hologic reported revenue of $1.0B (down 0.8% YoY) for Q2 FY2024, with a net profit of $169.9M (down 22.2% YoY) (16.7% margin). Cost of goods sold was $475.5M, operating expenses totaled $331.9M.
Key Financial Metrics
| Total Revenue | $1.0B |
|---|---|
| Net Profit | $169.9M |
| Gross Margin | 53.3% |
| Operating Margin | 20.7% |
| Report Period | Q2 FY2024 |
Revenue Breakdown
Hologic Q2 FY2024 revenue of $1.0B breaks down across 10 segments, led by Molecular Diagnostics at $255.4M (25.1% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Molecular Diagnostics | $255.4M | 25.1% |
| Breast Imaging | $234.9M | 23.1% |
| Other | $189.2M | 18.6% |
| Gyn Surgical | $115.6M | 11.4% |
| Cytology Perinatal | $70.7M | 6.9% |
| Asia Pacific | $64.4M | 6.3% |
| Interventional Breast Solutions | $60.4M | 5.9% |
| Skeletal Health | $15.5M | 1.5% |
| Blood Screening | $6.9M | 0.7% |
| Other Typeof Revenue | $4.8M | 0.5% |
Hologic Revenue by Segment — Quarterly Trend
Hologic revenue by segment across the last 4 reported quarters, showing how each business line (such as Molecular Diagnostics and Breast Imaging) has evolved quarter over quarter.
| Segment | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|
| Molecular Diagnostics | $255.3M | $252.7M | $254.4M | $258.7M |
| Breast Imaging | $219.9M | $230.9M | $204.2M | $209.4M |
| Gyn Surgical | — | — | — | $117.0M |
| Cytology Perinatal | $76.0M | $73.2M | $75.8M | — |
Hologic Annual Revenue by Year
Hologic annual revenue history includes year-by-year totals (for example, 2025 revenue was $4.1B).
| Year | Annual Revenue |
|---|---|
| 2025 | $4.1B |
| 2024 | $4.0B |
Hologic Quarterly Revenue & Net Profit History
Hologic results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $1.0B | +2.5% | $179.1M | 17.1% |
| Q4 FY2025 | $1.0B | +6.2% | $187.2M | 17.8% |
| Q3 FY2025 | $1.0B | +1.2% | $194.9M | 19.0% |
| Q2 FY2025 | $1.0B | -1.2% | $-17.4M | -1.7% |
| Q1 FY2025 | $1.0B | +0.9% | $201.0M | 19.7% |
| Q4 FY2024 | $988.0M | +0.4% | $178.6M | 18.1% |
| Q3 FY2024 | $1.0B | -1.5% | $194.5M | 19.2% |
| Q2 FY2024 | $1.0B | -0.8% | $169.9M | 16.7% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.02B | $1.01B | $988.0M | $1.02B | $1.01B | $1.02B | $1.05B | $1.05B |
| YoY Growth | -0.8% | -1.5% | 0.4% | 0.9% | -1.2% | 1.2% | 6.2% | 2.5% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $8.71B | $8.89B | $9.16B | $8.73B | $8.55B | $8.81B | $9.01B | $9.18B |
| Liabilities | $3.87B | $3.94B | $4.03B | $3.96B | $3.93B | $3.96B | $3.97B | N/A |
| Equity | $4.84B | $4.95B | $5.13B | $4.77B | $4.62B | $4.84B | $5.05B | $5.25B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $292.4M | $405.8M | $367.0M | $189.3M | $169.4M | $343.3M | $355.1M | $229.9M |